Stay updated on Batoclimab in Active Thyroid Eye Disease Clinical Trial
Sign up to get notified when there's something new on the Batoclimab in Active Thyroid Eye Disease Clinical Trial page.

Latest updates to the Batoclimab in Active Thyroid Eye Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed study information regarding batoclimab for Thyroid Eye Disease and the introduction of a new revision number. The study is now described as Quadruple-blind.SummaryDifference15%
- Check29 days agoChange DetectedThe page now indicates that the study has increased from 43 to 44 locations and has been marked as completed. Additionally, the revision number has been updated from v2.14.3 to v2.14.4.SummaryDifference1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Batoclimab in Active Thyroid Eye Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Batoclimab in Active Thyroid Eye Disease Clinical Trial page.